Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index; 31 of the 126 sources its claims cite were checked for support.
Abstract
Human gut microbiota is able to influence the host physiology by regulating multiple processes, including nutrient absorption, inflammation, oxidative stress, immune function, and anabolic balance. Aging is associated with reduced microbiota biodiversity, increased inter-individual variability, and over-representation of pathobionts, and these phenomena may have great relevance for skeletal muscle mass and function. For this reason, the presence of a gut-muscle axis regulating the onset and progression of age-related physical frailty and sarcopenia has been recently hypothesized. In this narrative review, we summarize the studies supporting a possible association between gut microbiota-related parameters with measures of muscle mass, muscle function, and physical performance in animal models and humans. Reduced muscle mass has been associated with distinct microbiota composition and reduced fermentative capacity in mice, and the administration of probiotics or butyrate to mouse models of muscle wasting has been associated with improved muscle mass. However, no studies have targeted the human microbiome associated with sarcopenia. Limited evidence from human studies shows an association between microbiota composition, involving key taxa such as Faecalibacterium and Bifidobacterium, and grip strength. Similarly, few studies conducted on patients with parkinsonism showed a trend towards a different microbiota composition in those with reduced gait speed. No studies have assessed the association of fecal microbiota with other measures of physical performance. However, several studies, mainly with a cross-sectional design, suggest an association between microbiota composition and frailty, mostly assessed according to the deficit accumulation model. Namely, frailty was associated with reduced microbiota biodiversity, and lower representation of butyrate-producing bacteria. Therefore, we conclude that the causal link between microbiota and physical fitness is still uncertain due to the lack of targeted studies and the influence of a large number of covariates, including diet, exercise, multimorbidity, and polypharmacy, on both microbiota composition and physical function in older age. However, the relationship between gut microbiota and physical function remains a very promising area of research for the future.
Overview
CoChat Summary
TL;DR
This narrative review summarizes animal and human evidence for a gut-muscle axis linking gut microbiota to muscle mass, muscle function, and physical frailty/sarcopenia in aging. It concludes that the association is biologically plausible and supported by limited studies, but causality remains uncertain because targeted human studies are lacking and many covariates confound both microbiota and physical function.
Key findings
- Animal studies support a possible gut-muscle axis: reduced muscle mass has been associated with distinct microbiota composition and reduced fermentative capacity in mice, and probiotics or butyrate administration improved muscle mass in mouse models of muscle wasting.
- No studies have targeted the human microbiome specifically associated with sarcopenia; limited human evidence shows associations between microbiota composition, involving taxa such as *Faecalibacterium* and *Bifidobacterium*, and grip strength.
- In a randomized controlled trial of 60 nursing home residents, a prebiotic containing inulin and fructooligosaccharides improved hand-grip strength after 13 weeks (12.4 ± 3.2 vs. 10.2 ± 4.1 kg, p = 0.04), although fecal microbiota composition was not assessed.
- Frailty, mostly assessed by the deficit accumulation model/Rockwood Frailty Index, was associated with reduced microbiota biodiversity and lower representation of butyrate-producing bacteria; one trial in 50 nursing home residents found a mild but statistically significant reduction in a 62-item frailty index after prebiotic administration.
Methods
- Narrative review; papers searched on PubMed as of 1 June 2019 using terms including microbiota AND “muscle function,” sarcopenia, “muscle mass,” “muscle wasting,” frailty, “gait speed,” “muscle strength,” “grip strength,” and “physical performance.”
- A systematic review approach was not possible due to the low number of human studies and heterogeneity of settings, participants, and outcome measures; human studies relevant to the primary aim were discussed, with animal studies included for possible pathophysiological mechanisms.
- The review summarizes studies on microbiota-related parameters with measures of muscle mass, muscle function, and physical performance, including grip strength, gait speed, timed up-and-go, and frailty indices.
Limitations
- The paper states that the causal link between microbiota and physical fitness remains uncertain due to lack of targeted studies and the influence of many covariates, including diet, exercise, multimorbidity, and polypharmacy, on both microbiota composition and physical function in older age.
- The paper states that most human studies are cross-sectional, so causality cannot be inferred; no human studies have directly assessed an association between gut microbiota composition and skeletal muscle mass in age-related sarcopenia.
- The paper states that frailty studies mostly used the Rockwood Frailty Index or Clinical Frailty Scale, which do not directly assess muscle function and performance; gait speed studies were not focused on older people with sarcopenia or physical frailty and did not follow geriatric assessment recommendations.
- Evident from the text: this is a narrative rather than systematic review, with a search limited to 1 June 2019, and much of the mechanistic evidence comes from animal models whose translation to humans is uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
16 Valid · 6 Not valid · 66 Not checked · 21 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Healthy, active older subjects, including centenarians, show a microbiota composition resembling that of adult subjects, with limited features of dysbiosis [45,46].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 1. Introduction > 1.2. Gut Microbiota: A Novel Player in Sarcopenia and Physical Frailty?
What the sources say
- Partly supportedcites [45] Kim S. Jazwinski S.M. The gut microbiota and healthy aging: A mini-review Gerontology 2018 64 513 520 10.1159/000490615 30025401 PMC6191326 sourceExperimental — accuracy not yet measured
In “The human gut microbiota” (page unavailable), the review says young adults and centenarians share a core microbiota, supporting a limited resemblance. But “Changes in the gut microbiota associated with longevity or healthy aging” (page unavailable) reports age-related compositional differences; it does not establish that healthy, active older people have an adult-like overall composition or only limited dysbiosis. (LLM, conf=0.84)
- Disputedcites [46] Biagi E. Nylund L. Candela M. Ostan R. Bucci L. Pini E. Nikkïla J. Monti D. Satokari R. Franceschi C. Through ageing, and beyond: Gut microbiota and inflammatory status in seniors and centenarians PLoS ONE 2010 5 e10667 10.1371/annotation/df45912f-d15c-44ab-8312-e7ec0607604d 20498852 PMC2871786 sourceExperimental — accuracy not yet measured
The Discussion (page not supplied) says young and elderly adults have comparable gut microbiota, but explicitly says centenarians differ significantly from the adult-like pattern and have lower diversity. The fecal-profile results likewise report significantly different microbiota profiles in centenarians. Thus the source contradicts the claim’s inclusion of centenarians. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Namely, the circulating levels of microbiota-derived indoxyl sulfate are positively associated with the expression of myostatin and atrogin-1 [29], representing two of the main negative regulators of skeletal muscle mass [30].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 1. Introduction > 1.2. Gut Microbiota: A Novel Player in Sarcopenia and Physical Frailty?
What the sources say
- Partly supportedcites [29] Enoki Y. Watanabe H. Arake R. Sugimoto R. Imafuku T. Tominaga Y. Ishima Y. Kotani S. Nakajima M. Tanaka M. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1 Sci. Rep. 2016 6 32084 10.1038/srep32084 27549031 PMC4994088 sourceExperimental — accuracy not yet measured
The Results (page not available in our copy) show that administering indoxyl sulfate increased myostatin and atrogin-1 expression in the skeletal muscle of half-nephrectomized mice. They do not establish a positive association between circulating indoxyl sulfate levels and expression: plasma trough levels only tended to rise in treated mice (p = 0.15). The cited study used administered indoxyl sulfate rather than testing a microbiota-derived exposure. (LLM, conf=0.86)
- Supportedcites [30] Sakuma K. Yamaguchi A. Sarcopenia and cachexia: Tha adaptations of negative regulators of skeletal muscle mass J. Cachexia Sarcopenia Muscle 2012 3 77 94 10.1007/s13539-011-0052-4 22476916 PMC3374017 source
The citation to this paper is attached to the description of myostatin and atrogin-1 as negative regulators of skeletal muscle mass, not to the preceding indoxyl-sulfate association, which cites [29]. The Sarcopenia section explicitly calls Atrogin-1 and myostatin common negative regulators; it does not need to establish the indoxyl-sulfate association to support the part attributed to [30]. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the administration of probiotics or butyrate to mouse models of muscle wasting has been associated with improved muscle mass”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > Abstract
What the sources say
- Partly supportedcites [66] Varian B.J. Goureshetti S. Poutahidis T. Lakritz J.R. Levkovich T. Kwok C. Teliousis K. Ibrahim Y.M. Mirabal S. Erdman S.E. Beneficial bacteria inhibit cachexia Oncotarget 2016 7 11803 11816 10.18632/oncotarget.7730 26933816 PMC4914249 sourceExperimental — accuracy not yet measured
The Results (Figure 1; page unavailable) report improved muscle measures in a mouse model of cancer-associated cachexia after treatment with the probiotic L. reuteri. The Experimental design section describes L. reuteri administration, but our copy provides no evidence that butyrate was administered or improved muscle mass (searched: butyrate). (LLM, conf=0.88)
- Partly supportedcites [67] Bindels L.B. Beck R. Schackman O. Martin J.C. De Backer F. Sohet F.M. Dewulf E.M. Pachikian B.D. Neyrinck A.M. Thissen J.P. Restoring specific Lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model PLoS ONE 2012 7 e37971 10.1371/journal.pone.0037971 22761662 PMC3384645 sourceExperimental — accuracy not yet measured
The Results report that two Lactobacillus strains increased tibialis muscle weight by 8% in leukemic mice, although gastrocnemius weight did not change significantly. This supports the probiotic part of the claim for specific strains and one muscle; our copy does not report butyrate administration or its effect on muscle mass (searched: butyrate). (LLM, conf=0.88)
- Partly supportedcites [71] Walsh M.E. Bhattacharya A. Staranatarajan K. Qaisar R. Sloane L. Rahman M.M. Kinter M. Van Remmen H. The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging Aging Cell 2015 14 957 970 10.1111/acel.12387 26290460 PMC4693467 sourceExperimental — accuracy not yet measured
The section “Butyrate prevents hindlimb muscle loss during aging” reports that aged mice given butyrate lost less hindlimb muscle mass than controls. The Experimental procedures describe a butyrate-containing diet, not probiotic administration; our copy does not support the probiotic part of the claim. (LLM, conf=0.89)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Finally, transplantation of the intestinal microbiota from pigs to lean germ-free mice resulted in significant changes of muscle fibers structure, resembling to that typical of pigs [51].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 2. Gut Microbiota and Muscle Mass > 2.1. The Microbiota as Transducer of Nutrient Signals
What the sources say
- Partly supportedcites [51] Yan H. Diao H. Xiao Y. Li W. Yu B. He J. Yu J. Zheng P. Mao X. Luo Y. Gut microbiota can transfer fiber characteristics and lipid metabolic profiles of skeletal muscle from pigs to germ-free mice Sci. Rep. 2016 6 31786 10.1038/srep31786 27545196 PMC4992887 sourceExperimental — accuracy not yet measured
The Results section ('The two groups of mouse recipients developed different body compositions, fiber characteristics and fiber type distributions') confirms that GF BALB/C mice colonized with porcine fecal suspension mirrored their pig donors in fiber type: MYH7 (slow type I) was higher and MYH4 (fast IIb) lower in RM versus YM at p < 0.05, and the Discussion states RP/RM exhibited higher type I and lower type IIb fibers. However, the morphological 'structure' measures the claim names — fiber diameter and cross-sectional area of the gastrocnemius — were only non-significant trends in both donors (p = 0.0994) and recipients (p = 0.0832), so 'significant changes of muscle fiber structure' overstates the source. Our copy also does not describe the germ-free recipients as 'lean'; the lean/obese contrast applies to the Yorkshire vs Rongchang pig donors. (LLM, conf=0.75)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The effects of protein intake on the gut microbiota composition, and the consequences for muscle mass deposition, may depend on protein quality and microbiota metabotype [54], so that the pro-anabolic response to protein intake, mediated by the microbiota, may be different on an individual basis.”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 2. Gut Microbiota and Muscle Mass > 2.1. The Microbiota as Transducer of Nutrient Signals
What the sources say
- Partly supportedcites [54] Liao Y. Peng Z. Chen L. Zhang Y. Cheng Q. Nüssler A.K. Bao W. Liu L. Yang W. Prospective views for whey protein and/or resistance training against age-related sarcopenia Aging Dis. 2019 10 158 174 10.14336/AD.2018.0325 30705776 PMC6345331 sourceExperimental — accuracy not yet measured
The section ‘Gut microbiota: a key factor for whey protein and/or resistance training against age-related sarcopenia?’ says protein quality affects gut microbiota in mice and discusses ways microbiota may influence skeletal muscle. It does not establish that the consequences for muscle mass deposition depend on protein quality or microbiota metabotype; the copy provides no page number for these passages. (LLM, conf=0.84)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
63 more claims · 7 with their cited sources checked
Create a free account to see all 109 claims and to verify the 95 references still open.
- It may state two separate claims as one. 37
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Anabolic resistance is associated with reduced gene expression in proteins involved in MPS, impaired protein absorption and digestion, loss of skeletal-muscle stem cells, and decreased amino-acid transportation in the skeletal muscle [19,137,138].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredIn the citing paper
“Gut microbiota dysbiosis is linked to age-related systemic inflammation, leading to impaired muscle function and increased proinflammatory cytokines, which are associated with higher risk of obesity [19].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 3. Gut Microbiota and Parameters of Muscle Function > 3.3. Gut Microbiota and Other Parameters of Physical Performance
“Similar intervention studies were performed in healthy adults, evaluating physical performance by measuring endurance capacity, which is not part of standard geriatric assessment [88,109].”
§ Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia > 3. Gut Microbiota and Parameters of Muscle Function > 3.1. Gut Microbiota and Muscle Strength
“In another experimental study, the administration of resveratrol, a polyphenol compound able to promote skeletal and cardiac muscle cell biogenesis and remodeling, to mouse models of heart failure resulted in significant changes in intestinal microbiota composition, but no improvement in muscle strength [88].”
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503 · cited 1×
“This condition frequently overlaps with physical frailty [3], representing the reduction of the capacity to maintain fitness, physical performance and sense of well-being over time and particularly after stressors such as acute illnesses [4].”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803 · cited 1×
“fractures, disability and mortality [1,2].”
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314
Guralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Cited by
Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02073-3 · Cited by 516
“Gut dysbiosis may be associated with pathologies such as asthma [31], cardiovascular disease [32], type 2 diabetes mellitus (T2DM) [33], renal failure [34], and sarcopenia [35].”
BackgroundEl Assar, M., Álvarez-Bustos, A., Sosa, P., Angulo, J., & Rodríguez-Mañas, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158713 · Cited by 371
“Myokine alteration Apelin increases mitocondriogenesis and reduces inflammation Myostatin inhibits muscle synthesis and promotes muscle catabolism and is inhibited by follistatin Adiponectin increases mitochondrial function and augments oxidative fibers Irisin improves mitochondrial function decreases ROS production a…”
BackgroundUnderstanding the gut microbiota and sarcopenia: a systematic review
Liu, C., Cheung, W., Li, J., Chow, S. K., Yu, J., Wong, S. H., Ip, M., Sung, J. J. Y., & Wong, R. M. Y. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12784 · Cited by 363
“More importantly, advanced age not only affects the muscle but also causes gut microbiome dysbiosis,(27) with altered microbial diversity and predominant bacteria, and lower beneficial bacterial metabolites.(28,29) Gut microbiota-derived”
BackgroundLing, Z., Liu, X., Cheng, Y., Yan, X., & Wu, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1867054 · Cited by 352
“The gut-muscle axis refers to the roles for the gut microbiota on the maintenance of whole body lean mass, skeletal muscle mass, and physical function (De Sire et al. 2018; Grosicki, Fielding, and Lustgarten 2018; Ni Lochlainn, Bowyer, and Steves 2018; Picca et al. 2018; Ticinesi et al. 2019).”
BackgroundBilski, J., Pierzchalski, P., Szczepanik, M., Bonior, J., & Zoladz, J. (2022) · Cells · doi:10.3390/cells11010160 · Cited by 251
“This may suggest that, in older people, the dysbiotic gut microbiota could influence the onset of sarcopenia and physical frailty also by promotion of malnutrition [123].”
BackgroundInfluential
Metadata
- Authors
- Ticinesi, A., Nouvenne, A., Cerundolo, N., Catania, P., Prati, B., Tana, C., & Meschi, T.
- Affiliations
- University of Parma (IT)
- Ospedale di Parma (IT)
- Corresponding author
- Ticinesi, Andrea
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-07-17
- Volume
- 11
- Issue
- 7
- Pages
- 1633
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6683074
- OpenAlex
- W2961066137
- Semantic Scholar
- fecf6f6df4b36ccd42a489508be21efdeb7072a1
- Cited by
- 418
- References
- 144
- Citations by year
- 2026: 60 · 2025: 61 · 2024: 88 · 2023: 73 · 2022: 49 · 2021: 44 · 2020: 36 · 2019: 6
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- gut microbiota, aging, sarcopenia, physical frailty, muscle mass, muscle function, gut-muscle axis, microbiome diversity, butyrate, probiotics, Faecalibacterium, Bifidobacterium, grip strength, walking speed, parkinsonism, physical performance
- MeSH terms
- Gastrointestinal Microbiome, Frailty, Aged, Animals, Humans, Muscle, Skeletal, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia. https://app.cochat.ai/papers/10.3390/nu11071633
- The paper
- Ticinesi, A., Nouvenne, A., Cerundolo, N., Catania, P., Prati, B., Tana, C., & Meschi, T. (2019). Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia. Nutrients. https://doi.org/10.3390/nu11071633
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
